Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 431,012 shares at $3.85 ($1.6M) on 2025-02-11, disclosed to the SEC on 2025-02-13.
Open-market sale of $1.6M RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 140,182 | $540K | 33.0% |
| 2 | $3.85 | 140,182 | $540K | 33.0% |
| 3 | $3.70 | 75,324 | $279K | 17.0% |
| 4 | $3.70 | 75,324 | $279K | 17.0% |
| Total | $3.80 avg | 431,012 | $1.6M | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |